VYNE

Q: What is the price of VYNE Therapeutics (VYNE) today?

The price of VYNE Therapeutics (VYNE) today is US$ 0,39, with a variation of -80.6% compared to the last year. The price of VYNE Therapeutics (VYNE) started the year trading around US$ 3,35 and today it is at US$ 0,39. Follow the real-time price chart, the historical price of VYNE Therapeutics (VYNE), and stock data from Ibovespa and international markets.

Q: When does VYNE Therapeutics (VYNE) pay dividends?

VYNE Therapeutics (VYNE) não distribuiu dividendos no último ano.

Q: VYNE Therapeutics (VYNE) is it worth it?

Currently, VYNE Therapeutics (VYNE) is priced at US$ 0,39, with a P/E of -0,50%, representing a deviation of -0,98% from its historical average P/E. In the last year, the stock showed a variation of -80.6% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -80,60%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of VYNE Therapeutics (VYNE)?

Investing in stocks of VYNE Therapeutics (VYNE) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of VYNE Therapeutics (VYNE) yield today?

The yield of VYNE Therapeutics (VYNE) was 25,60% in the last month, -80,60% in the last year and -99,73% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of VYNE Therapeutics (VYNE) today, the total investment would be US$ 39,00, based on the current price of US$ 0,39.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 7,57In 5 years: US$ 0,11In 10 years: 39,00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

VYNE Therapeutics Inc.

Price

US$ 0,39

variation (12m)

-80,60%

p/l

-0,50

p/vp

0,41

DIVIDEND YIELD

0,00%

price VYNE

BVMF

VYNE

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of VYNE

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

25,60%

3 months

-69,05%

1 year

-80,60%

2 years

-85,66%

5 years

-99,73%

10 years

0,00%

real profitability

profitability minus inflation.

1 month

25,60%

3 months

-69,16%

1 year

-81,45%

2 years

-86,91%

5 years

-99,80%

10 years

0,00%

Indicators VYNE

check out the fundamentals of VYNE Therapeutics shares

P/E

-0,50

Sector: -1,17 Industry: 37,54

P/SALES RATIO (PSR)

37,88

Sector: 1,90 Industry: 5,53

P/BV

0,41

Sector: 2,15 Industry: 12,46

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: 2,63%

ROA

-71,85%

Sector: -26,82% Industry: 6,26%

ROE

-82,64%

Sector: -29,96% Industry: 14,15%

ROIC

-1.303,72%

Sector: -411,72% Industry: 16,54%

NET MARGIN

-100,00%

Sector: -27,32% Industry: 13,46%

GROSS MARGIN

100,00%

Sector: 43,14% Industry: 89,24%

OPERATING MARGIN

-100,00%

Sector: -23,34% Industry: 29,60%

P/EBITDA

-0,43

Sector: 0,01 Industry: 28,61

P/EBIT

-0,43

Sector: -1,25 Industry: 45,61

P/ASSET

0,36

Sector: 1,24 Industry: 2,87

BVPS

0,90

Sector: 3,73 Industry: 31,09

EPS

-0,75

Sector: -0,77 Industry: 3,64

EQUITY / ASSETS

0,87

Sector: 0,45 Industry: 0,69

CAGR REVENUES 5 YEARS

-54,90%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

-33,12%

Sector: - Industry: -

VYNE indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
LLY	54,24	40,79	75,21%	0,70%	US$ 748,47 B	25,91%
ISRG	57,10	8,59	15,04%	0,00%	US$ 154,22 B	28,29%
TMO	30,19	3,92	12,99%	0,31%	US$ 198,37 B	15,12%
SNY	7,45	1,45	19,52%	4,60%	US$ 117,87 B	22,40%
MDT	26,06	2,52	9,68%	2,23%	US$ 121,45 B	13,63%
CVS	18,05	1,27	7,05%	3,41%	US$ 98,62 B	1,40%
ABT	16,70	4,59	27,50%	1,73%	US$ 233,46 B	32,43%
GSK	13,53	4,54	33,57%	3,78%	US$ 88,47 B	15,70%
NVS	17,46	6,02	34,49%	2,98%	US$ 253,30 B	25,52%
BSX	49,83	6,23	12,51%	0,00%	US$ 141,21 B	14,65%
TMDX	35,64	11,47	32,18%	0,00%	US$ 3,65 B	17,65%
HCA	15,62	-80,14	-513,25%	0,68%	US$ 99,22 B	8,61%
DHR	46,00	2,77	6,02%	0,58%	US$ 144,91 B	13,04%
INMD	6,23	1,53	24,58%	0,00%	US$ 961,70 M	42,09%
IDXX	47,09	33,79	71,76%	0,00%	US$ 49,29 B	25,09%
FMS	20,90	0,95	4,56%	2,93%	US$ 15,74 B	3,48%
PHG	90,38	2,15	2,38%	3,24%	US$ 25,85 B	1,45%
HUM	20,59	1,85	8,97%	1,27%	US$ 33,79 B	1,30%
RMD	27,03	6,65	24,62%	0,81%	US$ 39,71 B	27,88%

comparison of VYNE with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History VYNE

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY VYNE Therapeutics

VYNE Therapeutics Inc.

Average user rating I10

4.0 (0 people)

Estados Unidos

14 years

Foundation: 2011

2018

Year of debut on the stock exchange - 7 years

40

Employees

The Company VYNE Therapeutics Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 15,91 Milhões, having a net worth of $ 38,88 Milhões.

With a total of 40 employees, the company is listed in the sector of Health and categorized in industry of Pharmaceutical Products.

In the last 12 months the Company had a revenue of $ 420,00 Thousand, which generated a loss in the amount of $ -32,13 Milhões.

As for its main indicators, the Company has a P/E ratio of -0,50, a P/BV ratio of 0,41 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker VYNE.

Market value

US$ 15,91 Milhões

Net worth

US$ 38,88 Milhões

US$ 38.880.000,00

Assets

US$ 44,72 Milhões

US$ 44.720.000,00

Total Number of Shares

43,00 Milhões

43.000.000

Average Daily Trading Volume

US$ 2,57 Milhões

US$ 2.572.956,00

Sector

Health

Industry

Pharmaceutical Products

VYNE

VYNE revenue and profits

VYNE results

DRAG THE FRAME TO SEE MORE DATA

VYNE cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

VYNE

VYNE Therapeutics Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of VYNE

check out the fundamentals of VYNE Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY VYNE Therapeutics

VYNE Therapeutics Inc.

Estados Unidos

14 years

2018

40

PROFIT X PRICE VYNE

VYNE results

VYNE cash flow

evolution of assets - VYNE

VYNE balance sheet

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

LBPSW - 4D pharma

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

HCA - HCA Healthcare

LLY - Eli Lilly

Frequently Asked Questions